NL166688B - METHOD FOR PREPARING A THERAPEUTIC PREPARATION WITH ANTI-BIOTIC EFFECT, PREPARED PREPARATION, AND METHOD FOR PREPARING A 2-ETHER (6R, 7R) -2-2-SUBSTITURED 2-ETHER HYDROXYIMINOACETAMIDO) - CEF-3-EM-4-CARBONIC ACID COMPOUND. - Google Patents

METHOD FOR PREPARING A THERAPEUTIC PREPARATION WITH ANTI-BIOTIC EFFECT, PREPARED PREPARATION, AND METHOD FOR PREPARING A 2-ETHER (6R, 7R) -2-2-SUBSTITURED 2-ETHER HYDROXYIMINOACETAMIDO) - CEF-3-EM-4-CARBONIC ACID COMPOUND.

Info

Publication number
NL166688B
NL166688B NL7206403.A NL7206403A NL166688B NL 166688 B NL166688 B NL 166688B NL 7206403 A NL7206403 A NL 7206403A NL 166688 B NL166688 B NL 166688B
Authority
NL
Netherlands
Prior art keywords
ether
preparing
preparation
substitured
hydroxyiminoacetamido
Prior art date
Application number
NL7206403.A
Other languages
Dutch (nl)
Other versions
NL7206403A (en
NL166688C (en
Original Assignee
Glaxo Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26251025&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NL166688(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glaxo Lab Ltd filed Critical Glaxo Lab Ltd
Publication of NL7206403A publication Critical patent/NL7206403A/xx
Priority to NLAANVRAGE7905299,A priority Critical patent/NL177020C/en
Publication of NL166688B publication Critical patent/NL166688B/en
Application granted granted Critical
Publication of NL166688C publication Critical patent/NL166688C/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/40—Radicals substituted by oxygen atoms
    • C07D307/42—Singly bound oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/14—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by halogen atoms or by nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55—Acids; Esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/81—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/16—Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/60—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
NLAANVRAGE7206403,A 1971-05-14 1972-05-12 METHOD FOR PREPARING A THERAPEUTIC PREPARATION WITH ANTI-BIOTIC ACTION, PREPARED PREPARATION, AND METHOD FOR PREPARING A 2-ETHER (6R, 7R) -SUBRICATED-2-THEROXEDITERATED E-THEROXEDITERATE ) CEF -3-EM-4-CARBONIC ACID COMPOUND. NL166688C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NLAANVRAGE7905299,A NL177020C (en) 1971-05-14 1979-07-06 METHOD FOR PREPARING A THERAPEUTIC PREPARATION WITH ANTIBIOTIC EFFECT, THERAPEUTIC OBJECT, AND METHOD FOR PREPARING A THEREFORE ETHERS OF A (6R, 7R) -3-SUBOXYTHOXETHYL-2-ACEROXETHYL-2-ACEROXETHYLENE-7- (2- ) CEF-3-EM-4-CARBONIC ACID COMPOUND.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB1508271A GB1399086A (en) 1971-05-14 1971-05-14 Cephalosporin compounds
GB4588471 1971-10-01

Publications (3)

Publication Number Publication Date
NL7206403A NL7206403A (en) 1972-11-16
NL166688B true NL166688B (en) 1981-04-15
NL166688C NL166688C (en) 1985-01-16

Family

ID=26251025

Family Applications (1)

Application Number Title Priority Date Filing Date
NLAANVRAGE7206403,A NL166688C (en) 1971-05-14 1972-05-12 METHOD FOR PREPARING A THERAPEUTIC PREPARATION WITH ANTI-BIOTIC ACTION, PREPARED PREPARATION, AND METHOD FOR PREPARING A 2-ETHER (6R, 7R) -SUBRICATED-2-THEROXEDITERATED E-THEROXEDITERATE ) CEF -3-EM-4-CARBONIC ACID COMPOUND.

Country Status (22)

Country Link
JP (3) JPS531280B1 (en)
AT (1) AT336786B (en)
BE (1) BE783449A (en)
CA (1) CA1027554A (en)
CH (1) CH591497A5 (en)
CS (2) CS245753B2 (en)
CY (1) CY971A (en)
DE (2) DE2265234C2 (en)
DK (1) DK155187C (en)
ES (2) ES402651A1 (en)
FR (2) FR2137900B1 (en)
GB (1) GB1399086A (en)
HK (1) HK66078A (en)
IE (1) IE38172B1 (en)
IL (1) IL39429A (en)
KE (1) KE2895A (en)
MY (1) MY7800466A (en)
NL (1) NL166688C (en)
NO (1) NO154797C (en)
PH (1) PH11205A (en)
SE (1) SE457795B (en)
YU (2) YU41807B (en)

Families Citing this family (124)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4079178A (en) * 1971-05-14 1978-03-14 Glaxo Laboratories Limited Cephalosporins having (α-etherified oximino) acylamido groups at the 7-position
GB1445979A (en) * 1972-10-25 1976-08-11 Glaxo Lab Ltd Cephalosporin derivatives
GB1399086A (en) * 1971-05-14 1975-06-25 Glaxo Lab Ltd Cephalosporin compounds
US4033950A (en) * 1971-05-14 1977-07-05 Glaxo Laboratories Limited 3-Hydroxymethyl-7β-(2-alkoxy-or benzyloxyimino-2-arylacetamido)ceph-3-em-4-carboxylic acids and salts thereof
US4064346A (en) * 1971-05-14 1977-12-20 Glaxo Laboratories Limited 3-Acetoxymethyl-7β-(2-carboxy-methoxyimino-2-arylacetamido)ceph-3-em-4-carboxylic acids and salts thereof
US4138555A (en) 1971-05-14 1979-02-06 Glaxo Laboratories, Limited (6R,7R)-7-[2-aryl-2-(etherified oximino)acetamido]-3-carbamoyloxymethylceph-3-em-4-carboxylic acid 1-oxides
AR208283A1 (en) * 1973-03-15 1976-12-20 Fujisawa Pharmaceutical Co A PROCEDURE FOR THE PREPARATION OF DERIVATIVES OF 2-ALKYL-2-O 3-FEFEM-4-CARBOXYL ACID
CH617703A5 (en) * 1973-12-21 1980-06-13 Glaxo Operations Ltd Process for the preparation of the syn-isomer or of a mixture of syn- and anti-isomers of novel antibiotically active 7 beta -acylamino-ceph-3-em-4-carboxylic acids
US4095021A (en) 1973-12-21 1978-06-13 Glaxo Laboratories Limited 3-Carbamoyloxymethyl or N-methyl-carbamoyloxymethyl-7-[2-carboxymethoxyimino-2-(fur-2-yl or thien-2-yl)acetamido]ceph-3-em-4-carboxylic acids and derivatives thereof
US4144392A (en) 1973-12-21 1979-03-13 Glaxo Laboratories Limited Cephalosporins having at position-7 a carboxy substituted α-etherified hydroxyimino-arylacetamido group and at position-3 the residue of a sulphur nucleophile
GB1512957A (en) * 1974-08-23 1978-06-01 Glaxo Lab Ltd Gephalosporin antibiotics
DK154939C (en) * 1974-12-19 1989-06-12 Takeda Chemical Industries Ltd METHOD OF ANALOGUE FOR THE PREPARATION OF THIAZOLYLACETAMIDO-CEPHEM COMPOUNDS OR PHARMACEUTICAL ACCEPTABLE SALTS OR ESTERS THEREOF
US4200746A (en) 1974-12-20 1980-04-29 Glaxo Laboratories, Ltd. Cephalosporins
GB1522140A (en) * 1974-12-20 1978-08-23 Glaxo Lab Ltd Syn-7-(2-hydroxyiminoacetamido)-3-pyridiniummethyl cephalosporins methods for their preparation and compositions containing them
NO760358L (en) * 1975-02-04 1976-08-05 Fujisawa Pharmaceutical Co
GB1555471A (en) * 1975-06-19 1979-11-14 Glaxo Lab Ltd 7 carbamoylalkoxyimino acetamido 3 em 4 carboxylic acidsand derivatives thereof
DE2760123C2 (en) 1976-01-23 1986-04-30 Roussel-Uclaf, Paris 7-Aminothiazolyl-syn-oxyiminoacetamidocephalosporanic acids, their preparation and pharmaceutical compositions containing them
SE440655B (en) * 1976-01-23 1985-08-12 Roussel Uclaf SET TO MAKE NEW OXIME DERIVATIVES OF 7-AMINO-THIAZOLYL-ACETAMIDO-CEPHALOSPORANIC ACID
GB1575803A (en) 1976-03-09 1980-10-01 Fujisawa Pharmaceutical Co 3,7 disubstituted 3 cephem 4 carboxylic acid compounds andprocesses for the preparation thereof
IE44888B1 (en) * 1976-03-09 1982-05-05 Fujisawa Pharmaceutical Co 3,7-disubstituted-3-cephem-4-carboxylic acid compounds and processes for the preparation theroef
US4165430A (en) 1976-03-19 1979-08-21 Glaxo Laboratories Limited Cephalosporins having a 7-carboxy substituted α-etherified oximinoarylacetamido) group
FR2345153A1 (en) * 1976-03-25 1977-10-21 Roussel Uclaf NEW ALCOYLOXIMES DERIVED FROM 7-AMINO THIAZOLYL ACETAMIDO CEPHALOSPORANIC ACID, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS MEDICINAL PRODUCTS
US4166115A (en) * 1976-04-12 1979-08-28 Fujisawa Pharmaceutical Co., Ltd. Syn 7-oxoimino substituted derivatives of cephalosporanic acid
DK162391C (en) * 1976-04-12 1992-03-09 Fujisawa Pharmaceutical Co ANALOGY PROCEDURE FOR PREPARING SYN-ISOMERS OF 3,7-DISUBSTITUTED 3-CEPHEM-4-CARBOXYLIC ACID COMPOUNDS
GR63088B (en) * 1976-04-14 1979-08-09 Takeda Chemical Industries Ltd Preparation process of novel cephalosporins
US4278670A (en) * 1976-07-12 1981-07-14 Smithkline Corporation 7-Alpha-oxyiminoacylcephalosporins
US4066762A (en) * 1976-07-12 1978-01-03 Smithkline Corporation Derivatives of 7-(2-substituted-2-hydroxyiminoacetamido)-3-(1-substituted tetrazol-5-ylthiomethyl-3-cephem-4-carboxylic acid
FR2361895A1 (en) * 1976-08-20 1978-03-17 Roussel Uclaf NEW OXIMES DERIVED FROM 3-CARBAMOYLOXYMETHYL 7-AMINO THIAZOLYL ACETAMIDO CEPHALOSPORANIC, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS MEDICINAL PRODUCTS
GB1592149A (en) * 1976-10-08 1981-07-01 Fujisawa Pharmaceutical Co 3 7-disubstituted-3-cephem-4-carboxylic acid compounds and processes for preparation thereof
JPS53103493A (en) * 1977-02-18 1978-09-08 Takeda Chem Ind Ltd Cephalosporin derivatives and process for their preparation
FR2381053A1 (en) * 1977-02-18 1978-09-15 Roussel Uclaf NEW OXIMES DERIVED FROM 3-THIADIAZOLYL THIOMETHYL 7-AMINOTHIAZOLYL ACETAMIDO CEPHALOSPORANIC, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS MEDICINAL PRODUCTS
PH17188A (en) 1977-03-14 1984-06-14 Fujisawa Pharmaceutical Co New cephem and cepham compounds and their pharmaceutical compositions and method of use
SE439312B (en) * 1977-03-25 1985-06-10 Roussel Uclaf SET TO MAKE NEW OXIME DERIVATIVES OF 3-ACETOXIMETHYL-7-AMINOTIAZOLYLACETAMIDO CEPHALOSPORANIC ACID
FR2384779A1 (en) * 1977-03-25 1978-10-20 Roussel Uclaf NEW OXIMES DERIVED FROM 3-CHLORO OR 3-METHOXY 7-AMINO THIAZOLYL ACETAMIDO CEPHALOSPORANIC, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS MEDICINAL PRODUCTS
DE2714880A1 (en) * 1977-04-02 1978-10-26 Hoechst Ag CEPHEMDER DERIVATIVES AND PROCESS FOR THEIR PRODUCTION
DE2716677C2 (en) * 1977-04-15 1985-10-10 Hoechst Ag, 6230 Frankfurt Cephem derivatives and processes for their preparation
GB1599232A (en) * 1977-06-03 1981-09-30 Hoffmann La Roche 7-(2-oximinoacetamido)-cephalosporin derivatives
IT1192287B (en) * 1977-11-14 1988-03-31 Fujisawa Pharmaceutical Co PHARMACEUTICAL ACTION DERIVATIVES OF CEPHALOSPORANIC ACID AND RELATED PREPARATION PROCEDURE
SE445350B (en) * 1978-04-14 1986-06-16 Roussel Uclaf OXIMO DERIVATIVES OF 3-AZIDOMETHYL-7-AMINO-THIAZOLYL-ACETAMIDO-CEPHALOSPORANIC ACID AND ITS USE AS ANTIBIOTICS
FR2438051A2 (en) * 1978-10-05 1980-04-30 Roussel Uclaf 3-Azido:methyl-3-cephem-4-carboxylic acid derivs. - useful as broad-spectrum antibacterial agents and disinfectants (BE 15.10.79)
DE2822860A1 (en) * 1978-05-26 1979-11-29 Hoechst Ag CEPHEM DERIVATIVES AND METHOD FOR THEIR PRODUCTION
AR228726A1 (en) 1978-05-26 1983-04-15 Glaxo Group Ltd PROCEDURE FOR THE PREPARATION OF ANTIBIOTIC (6R, 7R) -7 - ((Z) -2- (2-AMINOTIAZOL-4-IL) -2- (2-CARBOXIPROP-2-OXIIMINO) ACETAMIDO) -3- (1- PIRIDINIOMETIL) CEF-3-EM-4-CARBOXILATO
DE2822861A1 (en) * 1978-05-26 1979-11-29 Hoechst Ag CEPHEMDER DERIVATIVES AND PROCESS FOR THEIR PRODUCTION
US4268509A (en) * 1978-07-10 1981-05-19 Fujisawa Pharmaceutical Co., Ltd. New cephem compounds and processes for preparation thereof
US4284631A (en) * 1978-07-31 1981-08-18 Fujisawa Pharmaceutical Co., Ltd. 7-Substituted cephem compounds and pharmaceutical antibacterial compositions containing them
IL58717A (en) * 1978-11-15 1983-05-15 Glaxo Group Ltd Derivatives of(6r,7r)-7-((z)-2-(2-aminothiazol-4-yl)-2-(carboxy-(lower alkyl or cycloalkyl)oxyimino)acetamido)-3-(2-alkyl-pyrazolium-1-ylmethyl)ceph-3-em-4-carboxylate,process for their preparation and pharmaceutical compositions comprising them
DE2914327A1 (en) * 1979-04-09 1980-10-30 Hoechst Ag CEPHEM DERIVATIVES AND METHOD FOR THEIR PRODUCTION
EP0025199B1 (en) * 1979-09-03 1984-10-31 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds, processes for their preparation and pharmaceutical compositions containing them
US4341777A (en) * 1979-09-10 1982-07-27 Glaxo Group Limited Cephalosporin antibiotic
EP0027599B1 (en) * 1979-10-12 1984-10-03 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds, processes for their preparation and pharmaceutical compositions containing them
EP0104671B1 (en) * 1980-02-18 1990-05-23 Roussel-Uclaf Oxime derivatives of 3-alkyloxy or 3-alkylthiomethyl-7-amino-thiazolylacetamido-cephalosporanic acid, their preparation, their use as medicines and compositions containing them
FR2476087A1 (en) * 1980-02-18 1981-08-21 Roussel Uclaf NOVEL OXIMES DERIVED FROM 3-ALKYLOXY OR 3-ALKYL-THIOMETHYL 7-AMINO THIAZOLYL ACETAMIDO CEPHALOSPORANIC ACID, PROCESS FOR PREPARING THEM AND THEIR APPLICATION AS MEDICAMENTS
EP0037797A3 (en) * 1980-03-11 1981-12-16 Ciba-Geigy Ag Cephalosporin derivatives, process for their preparation, pharmaceutical compositions containing them and their application
GR75644B (en) * 1980-06-18 1984-08-02 Fujisawa Pharmaceutical Co
ZA813787B (en) * 1980-06-18 1982-07-28 Fujisawa Pharmaceutical Co New cephem compounds and processes for preparation thereof
IL63207A (en) * 1980-07-24 1985-09-29 Lonza Ag Process for the preparation of 2-(2-aminothiazole-4-yl)-2-(syn)-methoxyiminoacetic acid esters
US4443444A (en) * 1980-08-11 1984-04-17 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
DE3175156D1 (en) * 1980-08-29 1986-09-25 Fujisawa Pharmaceutical Co New cephem compounds and processes for preparation thereof
US4416879A (en) * 1980-09-08 1983-11-22 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
NZ198350A (en) * 1980-09-25 1985-02-28 Toyama Chemical Co Ltd Cephalosporins and intermediates;pharmaceutical compositions
US4458072A (en) * 1980-10-10 1984-07-03 Hoffmann-La Roche Inc. Acyl derivatives
FR2494280A1 (en) * 1980-11-20 1982-05-21 Rhone Poulenc Ind NEW DERIVATIVES OF CEPHALOSPORINE AND THEIR PREPARATION
FR2494274A2 (en) * 1980-11-20 1982-05-21 Rhone Poulenc Ind NEW THIOVINYL-3 CEPHALOSPORINS, THEIR PREPARATION AND THE MEDICINES THAT CONTAIN THEM
FR2494276A2 (en) * 1980-11-20 1982-05-21 Rhone Poulenc Ind NEW VINYL-3 CEPHALOSPORINS, AND THEIR PREPARATION
FR2494279A1 (en) * 1980-11-20 1982-05-21 Rhone Poulenc Ind NEW OXACEPHALOSPORINS, THEIR PREPARATION AND THE MEDICINAL PRODUCTS CONTAINING THEM
FR2494275A2 (en) * 1980-11-20 1982-05-21 Rhone Poulenc Ind NEW DERIVATIVES OF VINYL-3 CEPHALOSPORINS AND THEIR PREPARATION
GR76342B (en) * 1981-02-02 1984-08-06 Fujisawa Pharmaceutical Co
FR2499995A1 (en) * 1981-02-13 1982-08-20 Roussel Uclaf 7-2-2-Amino-4-thiazolyl 2-hydroxy:imino-acetamido 3-cephem derivs. - 3-substd. by alkoxy- or alkyl-thio-methyl are antibiotics active against gram positive and gram negative bacteria
JPS6011917B2 (en) * 1981-04-09 1985-03-28 山之内製薬株式会社 Novel cephalosporin compounds
FR2505338A1 (en) * 1981-05-11 1982-11-12 Rhone Poulenc Sante 3-Substd. thio-vinyl 1-oxa-ceph-3-em-4-carboxylic acid antibacterials - esp. having 7-2-2-amino-4-thiazolyl-2-methoxy:imino-acetamido Gp., 3-thio substits. include thiadiazolyl and triazinyl Gps.
FR2505339A1 (en) * 1981-05-11 1982-11-12 Rhone Poulenc Sante 3-Substd. thio-vinyl 1-oxa-ceph-3-em-4-carboxylic acid antibacterials - esp. having 7-2-2-amino-4-thiazolyl-2-methoxy:imino-acetamido Gp., 3-thio substits. include thiadiazolyl and triazinyl Gps.
EP0070803A3 (en) * 1981-07-16 1984-05-02 Ciba-Geigy Ag Antibiotically active aminotriazolylcephalosporin derivatives and their preparation
GR76701B (en) * 1981-09-08 1984-08-29 Lilly Co Eli
JPS5859992A (en) * 1981-09-14 1983-04-09 Fujisawa Pharmaceut Co Ltd Novel cephen compound, its preparation and preventing agent and remedy for microbism
US4521413A (en) * 1981-09-14 1985-06-04 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
MA19602A1 (en) * 1981-09-30 1983-04-01 Ciba Geigy Ag AMINO-OXAZOLYL COMPOUNDS, PROCESS FOR THEIR PREPARATION, PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPOUNDS, AND THEIR APPLICATION
US4401668A (en) * 1981-10-02 1983-08-30 Eli Lilly And Company Pyrazinium substituted cephalosporins
US4474954A (en) * 1981-12-07 1984-10-02 Bristol-Myers Company Intermediates for cephalosporin derivatives
US4394503A (en) 1981-12-07 1983-07-19 Bristol-Myers Company Cephalosporin derivatives
US4406899A (en) 1982-03-04 1983-09-27 Bristol-Myers Company Cephalosporins
US4457929A (en) * 1982-03-29 1984-07-03 Bristol-Myers Company 3-Quaternary ammonium methyl)-substituted cephalosporin derivatives
PH19163A (en) * 1982-04-06 1986-01-16 Daiichi Seiyaku Co Cephalosporin derivatives
US4500526A (en) * 1982-06-28 1985-02-19 Bristol-Myers Company Cephalosporin derivatives
EP0097961B1 (en) 1982-06-28 1987-11-11 Bristol-Myers Company Cephalosporin derivatives, a process for the manufacture thereof and pharmaceutical compositions containing said derivatives
GB2125033B (en) * 1982-07-23 1985-08-29 Servipharm Ltd Cephalosporins
IL69246A (en) * 1982-08-07 1986-07-31 Tanabe Seiyaku Co 7-((2-aminothiazolyl-2-pyrrolidonyl or(piperidonyl)-oxyimino)acetamido)cephem carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
US4546101A (en) * 1982-09-10 1985-10-08 Fujisawa Pharmaceutical Co., Ltd. New cephem compounds useful for treating infectious diseases in human being and animals and processes for preparation thereof
FR2533216A1 (en) * 1982-09-22 1984-03-23 Toyama Chemical Co Ltd New cephalosporins and their salts.
JPS5973043A (en) * 1982-10-19 1984-04-25 House Food Ind Co Ltd Method for modifying quality of hardly soluble gelling agent
US4486586A (en) * 1983-02-10 1984-12-04 Bristol-Myers Company Cephalosporin derivatives
US4525473A (en) * 1983-03-30 1985-06-25 Bristol-Myers Company Cephalosporins
US4492694A (en) * 1983-04-12 1985-01-08 Eli Lilly And Company Indolylglycyl cephalosporin derivatives
GB2137993A (en) * 1983-04-12 1984-10-17 Lilly Co Eli Improvements in or relating to naphthylglycyl cephalosporin derivatives
US4492693A (en) * 1983-04-12 1985-01-08 Eli Lilly And Company Benzothienylglycyl cephalosporin derivatives
US4482553A (en) * 1983-04-12 1984-11-13 Eli Lilly And Company Benzothienylglycyl cephalosporin derivatives
DE3330605A1 (en) * 1983-08-25 1985-03-14 Hoechst Ag, 6230 Frankfurt CEPHALOSPORINE DERIVATIVES AND METHOD FOR THEIR PRODUCTION
JPS60132983A (en) * 1983-12-21 1985-07-16 Tanabe Seiyaku Co Ltd Thiazoleacetic acid derivative and its production
JPS60190783A (en) * 1983-12-21 1985-09-28 Sumitomo Seiyaku Kk Cephem compound
DE3485860T2 (en) * 1983-12-29 1993-01-14 Mochida Pharm Co Ltd CEPHALOSPORINE COMPOUNDS, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL PREPARATIONS.
JPS60142987A (en) * 1983-12-29 1985-07-29 Mochida Pharmaceut Co Ltd Cephalosporin derivative
GB8411954D0 (en) * 1984-05-10 1984-06-13 Glaxo Group Ltd Cephalosporin antibiotics
FI851934L (en) * 1984-05-30 1985-12-01 Ici Plc KEFALOSPORINDERIVAT.
IE58487B1 (en) * 1984-09-07 1993-09-22 Kaisha Maiji Seika New cephalosporin compounds and the production thereof
EP0182633A3 (en) * 1984-11-20 1987-09-02 Ici Pharma Cephalosporin derivatives
JPS61145186A (en) * 1984-12-20 1986-07-02 Meiji Seika Kaisha Ltd Novel cephem compound and preparation thereof
EP0186187B1 (en) * 1984-12-27 1992-02-26 Banyu Pharmaceutical Co., Ltd. Cephalosporin derivatives
US4840945A (en) * 1985-04-01 1989-06-20 Mochida Pharmaceutical Co., Ltd. Cephalosporin derivatives
US4874856A (en) * 1985-06-24 1989-10-17 Bristol-Myers Company 3-(substituted)propenyl-7-(aminothiazolylacetamido) ceph-3-em-4-carboxylic acids and esters thereof
US4708955A (en) * 1985-06-24 1987-11-24 Bristol-Myers Company 3-(substituted)propenyl-7-aminothiazol-ylcephalosporanic acids and esters thereof
US4814328A (en) * 1986-03-19 1989-03-21 Banyu Pharmaceutical Co., Ltd. Cephalosporin derivatives, and antibacterial agents
DE3623921A1 (en) * 1986-07-16 1988-01-21 Basf Ag OXIMETHER AND FUNGICIDES CONTAINING THEM
ZA877987B (en) * 1986-11-12 1988-08-31 Ici Pharma Antibiotic compounds
JPS63132893A (en) * 1986-11-25 1988-06-04 Mochida Pharmaceut Co Ltd Novel cephalosporin derivative, production thereof and antibacterial agent containing said derivative as active ingredient
US4880798A (en) * 1986-11-25 1989-11-14 Mochida Pharmaceutical Co., Ltd. Cephalosporin derivatives
US5262410A (en) * 1986-12-23 1993-11-16 Ici Pharma 3-heterocyclic thiomethyl cephalosporins
EP0272827A3 (en) * 1986-12-23 1990-02-07 ZENECA Pharma S.A. 3-heterocyclicthiomethyl cephalosphorins
US5189157A (en) * 1987-06-16 1993-02-23 Hoffmann La Roche Inc. Antibacterial cephalosporin compounds
DE3854684T2 (en) * 1987-07-23 1996-03-28 Zeneca Pharma Sa Cephalosporin compounds, processes for their preparation and pharmaceutical preparations containing them.
ATE131824T1 (en) * 1987-07-23 1996-01-15 Zeneca Pharma Sa CEPHALOSPORIN COMPOUNDS, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING SAME
KR900006811B1 (en) * 1988-05-11 1990-09-21 주식회사 럭 키 Cephalosphorin derivatives and its process
US5202315A (en) * 1989-05-11 1993-04-13 Lucky, Ltd. Cephalosporin compounds
GB8927871D0 (en) * 1989-12-08 1990-02-14 Beecham Group Plc Novel compounds
IN189046B (en) 1998-03-30 2002-12-14 Ranbaxy Lab Ltd
AU2820700A (en) * 1999-03-09 2000-09-28 Ranbaxy Laboratories Limited Process for the preparation of cefuroxime

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE311519B (en) * 1962-12-14 1969-06-16 Astra Ab
GB1208014A (en) * 1967-03-23 1970-10-07 Glaxo Lab Ltd Cephalosporins
GB1208015A (en) * 1967-03-23 1970-10-07 Glaxo Lab Ltd Cephalosporins
GB1241657A (en) * 1967-08-21 1971-08-04 Glaxo Lab Ltd Improvements in or relating to cephalosporin compounds
GB1279402A (en) * 1968-06-14 1972-06-28 Glaxo Lab Ltd Improvements in or relating to cephalosporin derivatives
US3641021A (en) * 1969-04-18 1972-02-08 Lilly Co Eli 3 7-(ring-substituted) cephalosporin compounds
DK143853C (en) * 1971-01-29 1982-04-05 Glaxo Lab Ltd METHOD OF ANALOGY FOR THE PREPARATION OF CEPHALOSPORINE COMPOUNDS OR UNTOXIC SALTS OR HYDRATES THEREOF
GB1399086A (en) * 1971-05-14 1975-06-25 Glaxo Lab Ltd Cephalosporin compounds

Also Published As

Publication number Publication date
CA1027554A (en) 1978-03-07
NL7206403A (en) 1972-11-16
JPS5328141A (en) 1978-03-16
SE457795B (en) 1989-01-30
MY7800466A (en) 1978-12-31
YU321379A (en) 1982-02-28
DE2223375A1 (en) 1972-11-23
CY971A (en) 1978-12-22
FR2137900A1 (en) 1972-12-29
CS245753B2 (en) 1986-10-16
DK155187B (en) 1989-02-27
ES430104A1 (en) 1976-10-01
YU126772A (en) 1982-02-28
IE38172L (en) 1972-11-14
NO154797C (en) 1986-12-29
YU41807B (en) 1988-02-29
CS245754B2 (en) 1986-10-16
CH591497A5 (en) 1977-09-30
AT336786B (en) 1977-05-25
ES402651A1 (en) 1975-11-01
IE38172B1 (en) 1978-01-18
JPS54135792A (en) 1979-10-22
NO154797B (en) 1986-09-15
IL39429A (en) 1978-04-30
NL166688C (en) 1985-01-16
HK66078A (en) 1978-11-24
JPS531280B1 (en) 1978-01-17
FR2137899B1 (en) 1976-08-20
BE783449A (en) 1972-11-13
DE2265234A1 (en) 1976-12-30
JPS6324993B2 (en) 1988-05-23
PH11205A (en) 1977-10-28
GB1399086A (en) 1975-06-25
IL39429A0 (en) 1972-07-26
DE2223375C2 (en) 1985-05-15
DE2265234C2 (en) 1983-02-10
FR2137900B1 (en) 1976-04-16
DK155187C (en) 1989-07-17
FR2137899A1 (en) 1972-12-29
ATA420872A (en) 1976-09-15
KE2895A (en) 1978-11-10

Similar Documents

Publication Publication Date Title
NL166688B (en) METHOD FOR PREPARING A THERAPEUTIC PREPARATION WITH ANTI-BIOTIC EFFECT, PREPARED PREPARATION, AND METHOD FOR PREPARING A 2-ETHER (6R, 7R) -2-2-SUBSTITURED 2-ETHER HYDROXYIMINOACETAMIDO) - CEF-3-EM-4-CARBONIC ACID COMPOUND.
NL172511C (en) METHOD FOR PREPARING OR MANUFACTURING A MEDICINE AGAINST INFLAMMATION
NL182369C (en) METHOD FOR PREPARING AN ORAL EXTENDED MEDICINE PREPARATION
NL183724C (en) METHOD FOR PREPARING C.Q. MANUFACTURE OF A PHARMACEUTICAL PREPARATION WITH ANTI-TUMOR ACTIVITY AND METHOD FOR PREPARING A PLATINACOOSTER DERIVATION COMPOUND SUITABLE FOR USE IN THE FOREGOING METHOD
NL153187B (en) PROCEDURE FOR PREPARING A PREPARATION WITH A WORM ANTI-WORK ACTIVITY, PREPARATION FORMED AND PROCEDURE FOR PREPARING SUITABLE COMPOUNDS.
NL185209C (en) METHOD FOR PREPARING A PHARMACEUTICAL PREPARATION WITH ANTIBACTERIAL ACTION, AND METHOD FOR PREPARING A DERIVATIVE OF (6R, 7R) -3-CARBAMOYLOXYMETHYL-7 - ((Z) -2- (2-FURYL) METHYL) ) ACEETAMIDO) -3-CEFEM-4-CARBONIC ACID.
NL153178B (en) PROCESS FOR PREPARING A PREPARATION WITH AN INSECT ACTION, PREPARATION FORMED AND PROCEDURE FOR PREPARING DIESIC ACID DERIVATIVES.
NL165386C (en) METHOD FOR MANUFACTURING AN INTAKE FILTER.
NL154741B (en) PROCESS FOR THE PREPARATION OF A MEDICINAL PRODUCT WITH ANTIBIOTIC ACTION, AS WELL AS THE OBTAINED PREPARED MEDICINAL PRODUCT AND PROCEDURE FOR THE PREPARATION OF AN ETHER DERIVED FROM AN (6R, 7R) -3-ACYLOXYL-IN-2-ARYL-2-YL-YL-IN-YL-IN-2-YL CEF-3-EM-4-CARBONIC ACID COMPOUND.
NL171587C (en) METHOD FOR PREPARING A PHARMACEUTICAL PREPARATION WITH ANACTIVITY AGAINST BACTERIA, AND METHOD FOR PREPARING AN SUITABLE ACTIVE COMPOUND.
NL179057C (en) METHOD FOR PREPARING OR MANUFACTURING A PHARMACEUTICAL PREPARATION WITH ANTIBACTERIAL ACTION, AND A METHOD FOR PREPARING A 7- (ALPHA-AMINOACETYLAMINO) -CIVEME-4-CARBON-4-CARBONYLENE.
NL176565C (en) METHOD FOR PREPARING OR MANUFACTURING A PHARMACEUTICAL PREPARATION WITH HYPOTENSIVE ACTION AND METHOD FOR PREPARING COMPOUNDS SUITABLE FOR USE IN THE FOREGOING PROCESS
NL171898B (en) METHOD FOR MANUFACTURING AN ANALGETIC; AND METHOD FOR PREPARING SUITABLE COMPOUNDS.
NL148784B (en) METHOD OF PREPARING AN INSECTICIDE PREPARATION.
NL154720B (en) PROCESS FOR PREPARING A PREPARATION WITH AN ACTION AGAINST INSECTS, FORMED PREPARATION AND PROCEDURE FOR THE PREPARATION OF DIESIC ACID DERIVATIVES.
NL169401C (en) METHOD FOR PREPARING THE PLANT GROWTH INFLUENCING PREPARATIONS AND METHOD FOR INFLUENCING PLANT GROWTH WITH AN ETHENE-BREAKING COMPOUND
NL139749B (en) METHOD OF PREPARING PENICILLINS SUITABLE FOR ORAL ADMINISTRATION, AND METHOD OF PREPARING A THERAPEUTIC AND FORMED THERAPEUTIC PREPARATION.
NL180978C (en) METHOD FOR MANUFACTURING A PHARMACEUTICAL PREPARATION WITH SECRETORIC AND / OR ANTI-COUGHTING ACTION, AND A METHOD FOR PREPARING A COMPOUND SUITABLE FOR USE IN THE FOREGOING METHOD
NL173242C (en) METHOD FOR PREPARING OR MANUFACTURING A PHARMACEUTICAL PREPARATION WITH ANTI-TUMOR ACTIVITY
NL176569B (en) METHOD FOR PREPARING MEDICINES WITH DIURETIC ACTIVITY, AND METHOD FOR PREPARING SUITABLE COMPOUNDS.
NL166474C (en) PROCESS FOR PREPARING NEW N-ACYL-3-INDOLYLACETIC ACID DERIVATIVES, WITH ANTI-INFLAMMATORY, ANTI-ANTI-ANTI-PAINT EFFECTS, A PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL PREPARATION PREPARED FOR A PREPARED PREPARATION, PREPARED THEREFORE,
NL174944C (en) METHOD FOR PREPARING OR MANUFACTURING A MEDICINAL PRODUCT WITH ANTIBIOTIC EFFICACY, AND METHOD FOR PREPARING A HETACILLINE COMPOUND
NL177750C (en) METHOD FOR PREPARING, RESPECTIVELY MANUFACTURING, A PHARMACEUTICAL PREPARATION WITH A HEART EFFECT AND METHOD FOR PREPARING USE THEREOF NEW ISOCHINOLINE DERIVATIVES
NL180276C (en) METHOD FOR PREPARING OR MANUFACTURING A PREPARATION INTENDED FOR VETERINARY USE
NL144328B (en) METHOD OF PREPARING AN ANTIBIOTIC, AS WELL AS FOR PREPARING A THERAPEUTIC PREPARATION CONTAINING THIS ANTIBIOTIC AND THE PREPARATION PREPARED ITSELF.

Legal Events

Date Code Title Description
P1 Automatically granted patents, except
NP1G Patent granted (not automatically) [patent specification modified]
V4 Discontinued because of reaching the maximum lifetime of a patent